Estimates of bivalent mRNA vaccine durability in preventing COVID-19-associated hospitalization and critical illness among adults with and without immunocompromising conditions - VISION Network, September 2022-April 2023

Estimates of bivalent mRNA vaccine durability in preventing COVID-19-associated hospitalization and critical illness among adults with and without immunocompromising conditions - VISION Network, September 2022-April 2023 Journal Article uri icon

Overview

Link to Article

10.1016/j.ajt.2023.06.004

authors

Link-Gelles, R.

Weber, Z. A.

Reese, S. E.

Payne, A. B.

Gaglani, M.

Adams, Kenneth F., PhD

Kharbanda, A. B.

Natarajan, K.

DeSilva, Malini B., MD, MPH HealthPartners Author

Dascomb, K.

Irving, S. A.

Klein, N. P.

Grannis, S. J.

Ong, T. C.

Embi, P. J.

Dunne, M. M.

Dickerson, M.

McEvoy, Charlene E., MD, MPH HealthPartners Author

Arndorfer, J.

Naleway, A. L.

Goddard, K. A. B.

Dixon, B. E.

Griggs, E. P.

Hansen, J.

Valvi, N.

Najdowski, M.

Timbol, J.

Rogerson, C.

Fireman, B. H.

Fadel, W. F.

Patel, P. D.

Ray, C. S.

Wiegand, R.

Ball, S.

Tenforde, M. W.

publication date

2023

published in

American Journal of Transplantation Journal

Research

keywords

COVID-19

COVID-19 Vaccines

Coronavirus Infections

Critical Care

Hospitalization

Additional Document Info

volume

issue